Stockscreener 앱 받기
0.8801
13.72%
-0.1399
시간 외 거래:
.89
0.0099
+1.12%
전일 마감가:
$1.02
열려 있는:
$0.95
하루 거래량:
14.10M
Relative Volume:
2.82
시가총액:
$102.41M
수익:
-
순이익/손실:
$-119.76M
주가수익비율:
-0.7929
EPS:
-1.11
순현금흐름:
$-55.17M
1주 성능:
-23.47%
1개월 성능:
-90.67%
6개월 성능:
-80.22%
1년 성능:
-70.27%
1일 변동 폭
$0.8382
$0.9901
1주일 범위
$0.8382
$1.15
52주 변동 폭
$0.8382
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
명칭
Applied Therapeutics Inc
전화
212-220-9226
주소
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
APLT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.8801 | 102.41M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-11-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | 개시 | William Blair | Outperform |
| 2024-03-26 | 개시 | RBC Capital Mkts | Outperform |
| 2024-02-22 | 개시 | Leerink Partners | Outperform |
| 2022-01-04 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-08-27 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-06-25 | 재개 | Goldman | Neutral |
| 2020-10-08 | 개시 | Truist | Buy |
| 2020-04-22 | 개시 | Goldman | Buy |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2019-06-10 | 개시 | Citigroup | Buy |
| 2019-06-10 | 개시 | Cowen | Outperform |
| 2019-06-10 | 개시 | Robert W. Baird | Outperform |
모두보기
Applied Therapeutics Inc 주식(APLT)의 최신 뉴스
Applied Therapeutics appoints new Executive Chairman By Investing.com - Investing.com Canada
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Eastern Progress Online
Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data - Benzinga
APLT COURT REMINDER: Applied Therapeutics, Inc. Investors that Lost Money when Stock Plummeted 80% are Encouraged to Contact BFA Law (NASDAQ:APLT) - AccessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesAPLT - PR Newswire
Applied Therapeutics appoints new Executive Chairman - Investing.com
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - The Malaysian Reserve
APPLIED THERAPEUTICS BREAKING NEWS: BFA Law Announces that - GlobeNewswire
APPLIED THERAPEUTICS BREAKING NEWS: BFA Law Announces that Applied Therapeutics, Inc. has been Sued for Securities Fraud – Investors with Losses Urged to Contact the Firm (NASDAQ:APLT) - Business Upturn
Royal Bank of Canada Issues Pessimistic Forecast for Applied Therapeutics (NASDAQ:APLT) Stock Price - MarketBeat
Applied Therapeutics, Inc. Announces Board Changes - Marketscreener.com
Applied Therapeutics CEO Shendelman Steps Down - MarketWatch
Applied Therapeutics Faces Leadership Changes and Regulatory Hurdles - TipRanks
Applied Therapeutics sees leadership shuffle, delays drug submission - Investing.com
Applied Therapeutics Appoints John H. Johnson as Executive Chairman - GlobeNewswire
Applied Therapeutics Overhauls Leadership Amid Major Setbacks in Drug Approval Journey - StockTitan
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Applied Therapeutics, Inc. - PR Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - Markets Insider
ROSEN, A LEADING LAW FIRM, Encourages Applied Therapeutics, - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. Purchasers to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
APLT Deadline to Lead in Securities Fraud Lawsuit is February 18, 2025Contact Kaplan Fox & Kilsheimer LLP - The Globe and Mail
Class Action Filed Against Applied Therapeutics, Inc. - GlobeNewswire
Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to Join – Contact - EIN News
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class ActionAPLT - PR Newswire
Applied Therapeutics, Inc Announces Chief Executive Officer Changes - Marketscreener.com
APLT INVESTOR ALERT: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Lawsuit - The Malaysian Reserve
APLT INVESTOR ALERT: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT) - GlobeNewswire Inc.
Deadline to Lead in Securities Fraud Lawsuit Against Applied Therapeutics, Inc. (APLT) is February 18, 2025Contact Kaplan Fox & Kilsheimer LLP - The Globe and Mail
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
APLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
APLT Stock Hits 52-Week Low at $1.01 Amid Market Challenges - Investing.com
Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire
Drugmaker Sued Over Optimistic Statements Before FDA Rejection - Bloomberg Law
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
Galactosemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, - openPR
Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP - TipRanks
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors - GlobeNewswire
Franklin Resources Inc. Reduces Stock Position in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat
Applied Therapeutics' SWOT analysis: rare disease biopharma stock faces regulatory hurdles - Investing.com Canada
Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Investors to Connect - AccessWire
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation - AccessWire
Applied Therapeutics' SWOT analysis: rare disease biopharma stock faces regulatory hurdles By Investing.com - Investing.com South Africa
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Applied Therapeutics, Inc. (APLT) And Encourages Stockholders to Reach Out - AccessWire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Stockholders to Connect - AccessWire
Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - AccessWire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors - Business Wire
Law Offices of Howard G. Smith Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors - Marketscreener.com
Applied Therapeutics, Inc. (NASDAQ:APLT) Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
Applied Therapeutics Inc (APLT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Applied Therapeutics Inc 주식 (APLT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Perfetti Riccardo | Chief Medical Officer |
Aug 22 '24 |
Sale |
5.83 |
22,681 |
132,230 |
986,853 |
| Shendelman Shoshana | President and CEO |
Aug 13 '24 |
Sale |
6.18 |
357,423 |
2,208,874 |
4,810,430 |
| Shendelman Shoshana | President and CEO |
Aug 12 '24 |
Sale |
5.98 |
300,000 |
1,794,000 |
5,167,853 |
| Shendelman Shoshana | President and CEO |
Aug 14 '24 |
Sale |
5.93 |
119,591 |
709,175 |
4,690,839 |
2.88%
2.65%
자본화:
|
볼륨(24시간):